Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Microbiome
Elanco and Ginkgo launch animal health company
by Matt Blois
April 16, 2022
| A version of this story appeared in
Volume 100, Issue 13
Elanco Animal Health and Ginkgo Bioworks are launching BiomEdit, a company that will use microbiome science to develop drugs, nutritional products, and disease-monitoring methods for livestock. The new firm hopes to address antibiotic resistance and improve sustainability. It is starting up with $40 million in funding from outside investors. Elanco is putting its microbiome R&D initiative into BiomEdit to focus on pet health. Elanco and Ginkgo will have a combined 40% stake in the company.
Chemical & Engineering News
ISSN 0009-2347
Copyright © 2025 American Chemical Society
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X